IFNA1 and systemic lupus erythematosus: SLE patients showed significantly higher serum IFN activities (97.6 (22.8–173.3) (median (IQR), n = 40, p < 0.001), while patients with other rheumatic diseases and healthy individuals showed almost zero serum IFN activities (Fig. 1).